Skip to content
Screener

Solesence, Inc. SLSN Q2 2025 earnings

Reported July 31, 2025 · After market close

Revenue$20.4M
EPS$0.04

Next report

Nov 16, 2026 (in 3 months)

Financials

Q2 2025

Income statement

See full
Revenue$20.4M+56.1%
Gross profit$6.4M+72.3%
Operating income$2.5M+136%
Net income$3.2M+278%
EPS (diluted)$0.04+300%

Balance sheet

See full
Cash & equivalents$4.1M+74.2%
Total debt$10.7M-0.4%
Total equity$14.4M+21.0%
Total assets$60.0M+46.8%

Cash flow

See full
Operating cash flow-$654.0K-15.8%
CapEx$1.4M+195%
Free cash flow-$1.8M-72.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$364.54M—
Enterprise value$371.14M—
P/S5.7×—

Profitability

See full
Gross margin29%+5.0pp
Operating margin9.2%+7.6pp

Returns & leverage

See full
Debt / equity0.7×-0.2×
Current ratio1.7×0.0×

Segments

By product

See full
Consumer Products$17.5M+56.6%
Personal Care Ingredients$2.7M+54.0%
Advanced Materials$128.0K+26.7%

By geography

See full
Non Us$2.5M+427%

FAQ

When did Solesence, Inc. report Q2 2025 earnings?
Solesence, Inc. (SLSN) reported Q2 2025 earnings on July 31, 2025 after market close.
What were Solesence, Inc.'s Q2 2025 revenue and EPS?
Solesence, Inc. reported revenue of $20.4M and eps of $0.04 for Q2 2025.
How did Solesence, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 56.1% from $13.0M a year earlier and eps grew 174.3% from $0.01.
Where can I find Solesence, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-004923) and the 10-Q periodic report (0001999371-25-011366) directly on SEC EDGAR. The filing index links above go to sec.gov.